Head/Neck Cancer

Top Story

Stress and cancer: Mindfulness is pivotal component to improve outcomes

August 24, 2015

Stress hormones are released when the body responds to physical, mental or emotional pressures.

These stress hormones — such as epinephrine and norepinephrine — increase blood pressure, heart rate and blood glucose levels.

In the Journals

Model predicts hearing loss after chemoradiotherapy for head and neck cancer

August 21, 2015
A model composed of patient and treatment characteristics predicted hearing level after chemoradiotherapy for patients with head and neck cancer, according to results of…

MedImmune acquires Inovio HPV cancer treatment for $700 million

August 15, 2015
Inovio Pharmaceuticals has begun collaboration and sold the exclusive rights to an HPV types 16 and 18 vaccine to MedImmune, the biologics research and development arm…
In the Journals

Bone marrow toxicity limited in most patients after radioiodine therapy for DTC

August 12, 2015
Long-term bone marrow function is not compromised after radioiodine treatment for thyroid cancer, according to research in The Journal of Clinical Endocrinology &
CME
Updates in Immunotherapy – Philadelphia 2015

Updates in Immunotherapy – Philadelphia 2015

This activity is supported by an educational grant from Merck & Co., Inc.

The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval…
More »
Meeting News Coverage Video
thumbnail for video 4099003660001

VIDEO: Ethical issues arise in genetic screening of thyroid cancer

March 7, 2015
SAN DIEGO — In this video exclusive, M. Sara Rosenthal, MD, director of the program for bioethics at the…
More »
Lorenzo Cohen, PhD

Stress and cancer: Mindfulness is pivotal component to improve outcomes

August 24, 2015
Stress hormones are released when the body responds to physical, mental or emotional pressures.These stress hormones — such as epinephrine and…
In the Journals

Model predicts hearing loss after chemoradiotherapy for head and neck cancer

August 21, 2015
A model composed of patient and treatment characteristics predicted hearing level after chemoradiotherapy for patients with head and neck cancer…

MedImmune acquires Inovio HPV cancer treatment for $700 million

August 15, 2015
Inovio Pharmaceuticals has begun collaboration and sold the exclusive rights to an HPV types 16 and 18 vaccine to MedImmune, the biologics research…
In the Journals

Bone marrow toxicity limited in most patients after radioiodine therapy for DTC

August 12, 2015
Long-term bone marrow function is not compromised after radioiodine treatment for thyroid cancer, according to research in The Journal of Clinical
Updates in Immunotherapy – Philadelphia 2015

Updates in Immunotherapy – Philadelphia 2015

August 18, 2015 Expires: 8/17/2016
The promise of immunotherapy in oncology has become a reality with the US Food and Drug Administration (FDA) approval of the programmed death-1…
Perspective

Persistent HPV16 DNA in oral rinses predicts oropharyngeal cancer recurrence

July 31, 2015
The presence of HPV type 16 DNA in oral rinses following treatment for HPV-related oropharyngeal cancer corresponded with poor prognosis and may…
Top Takeaways from ASCO: HPV-associated head and neck cancer Meeting News Coverage

Top Takeaways from ASCO: HPV-associated head and neck cancer

July 30, 2015
CHICAGO — De-intensified chemoradiation was efficacious in patients with low-risk, HPV-associated oropharyngeal squamous cell carcinoma…
David J. Adelstein, MD, FACP Meeting News Coverage

Top Takeaways from ASCO: Therapeutic dosing in head and neck cancer

July 30, 2015
CHICAGO — Cisplatin administered in a low-dose, weekly regimen may not be equivalent to standard high-dose, intermittent cisplatin in locally…
Charis Eng, MD, PhD In the Journals

Risk calculator an accurate, cost-effective prescreening tool for PTEN mutations

July 30, 2015
The PTEN Cleveland Clinic score appeared to be a cost-effective prescreening tool to identify patients with Cowden-like disease who are appropriate…
SupplementPublication Exclusive

Perspectives from ASCO 2015: A HemOnc Today Special Report

HemOnc Today, July 25, 2015
This year’s ASCO Annual Meeting featured the theme “Illumination and Innovation: Transforming Data into Learning.”As such, meeting…
More Headlines »
morganatic-roan